Vitro Biopharma, Inc. Annual Net Cash Provided by (Used in) Investing Activities in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
Vitro Biopharma, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from 2010 to 2023.
  • Vitro Biopharma, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending January 31, 2024 was -$486.000.
  • Vitro Biopharma, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was -$195K, a 37% increase from 2022.
  • Vitro Biopharma, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$310K.
  • Vitro Biopharma, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2015 was -$11.8K, a 344% decline from 2014.
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$195K +$115K +37% Nov 1, 2022 Oct 31, 2023 10-K 2024-01-29
2022 -$310K Nov 1, 2021 Oct 31, 2022 10-K 2024-01-29
2015 -$11.8K -$9.17K -344% Nov 1, 2014 Oct 31, 2015 10-K 2016-09-22
2014 -$2.66K +$7.12K +72.8% Nov 1, 2013 Oct 31, 2014 10-K 2016-09-22
2013 -$9.79K -$3.76K -62.3% Nov 1, 2012 Oct 31, 2013 10-K 2015-02-13
2012 -$6.03K +$161 +2.6% Nov 1, 2011 Oct 31, 2012 10-K 2014-02-12
2011 -$6.19K +$8.94K +59.1% Nov 1, 2010 Oct 31, 2011 10-K 2013-02-12
2010 -$15.1K Nov 1, 2009 Oct 31, 2010 10-K/A 2012-02-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.